Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ENJUVIA

ESTROGENS, CONJUGATED SYNTHETIC B

Standard Dose
0.3MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ENJUVIA is listed in Drugs@FDA under application 021609 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTROGENS, CONJUGATED SYNTHETIC B Form and strength TABLET; ORAL - 0.3MG Sponsor DURAMED Submission history Latest submission status date: 2004-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview ENJUVIA is listed in Drugs@FDA under application 021609 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTROGENS, CONJUGATED SYNTHETIC B Form and strength TABLET; ORAL - 0.3MG Sponsor DURAMED Submission history Latest submission status date: 2004-12-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.